These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3933225)

  • 41. DNA vaccines against chronic lung infections by Pseudomonas aeruginosa.
    Staczek J; Gilleland LB; van der Heyde HC; Gilleland HE
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):147-53. PubMed ID: 12832118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.
    Meynet E; Laurin D; Lenormand JL; Camara B; Toussaint B; Le Gouëllec A
    Vaccine; 2018 Mar; 36(14):1893-1900. PubMed ID: 29506924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization of mice and chinchillas against Pseudomonas aeruginosa.
    Lusis PI; Soltys MA
    Can J Comp Med; 1971 Jan; 35(1):60-6. PubMed ID: 4251417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa.
    Markham RB; Pier GB
    Rev Infect Dis; 1983; 5 Suppl 5():S957-62. PubMed ID: 6419317
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinico-immunological trials of Pseudomonas aeruginosa vaccine.
    Stanislavsky ES; Balayan SS; Sergienko AI; Makarenko TA; Edvabnaya LS; Krohina MA; Rusanov VM
    Vaccine; 1991 Jul; 9(7):491-4. PubMed ID: 1910233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-toxin A conjugate vaccine: effect of a booster dose on antibody levels in humans.
    Cryz SJ; Sadoff JC; Fürer E
    Infect Immun; 1988 Jul; 56(7):1829-30. PubMed ID: 2454893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
    Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
    Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tolerability and immunogenicity of a polyvalent Pseudomonas aeruginosa extract vaccine in human volunteers.
    Martindale JJ; Ganzinger U; Steinmüller W; Millendorfer A; Ambrosch F; Kollaritsch H; Wiedermann G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 May; 268(3):376-85. PubMed ID: 3136608
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection.
    Farajnia S; Peerayeh SN; Tanomand A; Majidi J; Goudarzi G; Naghili B; Rahbarnia L
    Can J Microbiol; 2015 Jan; 61(1):60-4. PubMed ID: 25496361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Immunogenic properties of a polyvalent vaccine against Pseudomonas aeruginosa].
    Serafińska D; Bukowska D; Sokołowska K; Nasiłowski W
    Pol Tyg Lek; 1980 Jul; 35(27):1013-5. PubMed ID: 6775310
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
    Minukhin VV; Tsyganenko VIa
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the immunogenicity of the Pseudomonas aeruginosa polyvalent corpuscular vaccine in human volunteers.
    Meitert E; Meitert T; Petrovici M; Sima F; Savulian C; Mitrică N; Georgescu C; Costache G
    Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):309-16. PubMed ID: 122593
    [No Abstract]   [Full Text] [Related]  

  • 54. Protective mechanisms of experimental vaccine-induced immunity to Pseudomonas aeruginosa.
    Lieberman MM
    Surv Synth Pathol Res; 1985; 4(4):312-22. PubMed ID: 3939159
    [No Abstract]   [Full Text] [Related]  

  • 55. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R; Sharma A; Wu W; Sung B; Worgall S
    Vaccine; 2017 Dec; 35(51):7174-7180. PubMed ID: 29126807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immune response to a Pseudomonas aeruginosa outer membrane protein vaccine.
    Jang IJ; Kim IS; Park WJ; Yoo KS; Yim DS; Kim HK; Shin SG; Chang WH; Lee NG; Jung SB; Ahn DH; Cho YJ; Ahn BY; Lee Y; Kim YG; Nam SW; Kim HS
    Vaccine; 1999 Jan; 17(2):158-68. PubMed ID: 9987150
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model.
    Elhosary MA; Bahey-El-Din M; AbdelBary A; El Guink N; Aboushleib HM
    Microb Pathog; 2019 Jun; 131():181-185. PubMed ID: 30978430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the human immune response to a polysaccharide vaccine from Pseudomonas aeruginosa.
    Pier GB; Thomas DM
    J Infect Dis; 1983 Aug; 148(2):206-13. PubMed ID: 6411830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody responses of burned patients immunized with a polyvalent Pseudomonas vaccine.
    Jones RJ
    J Hyg (Lond); 1979 Jun; 82(3):453-62. PubMed ID: 109501
    [TBL] [Abstract][Full Text] [Related]  

  • 60. X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosa.
    Li Y; Wang Z; Liu X; Tang J; Peng B; Wei Y
    Sci Rep; 2016 Feb; 6():18823. PubMed ID: 26879055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.